Cabometyx 40 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FSCA8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $100,933
Award facts
- Contract value 100% obligated
- $100,933.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $100,933.08 to DMS Pharmaceutical Group Inc. for 30 tablets of CABOMETYX 40 MG, an oncology medication used in cancer treatment. This firm fixed-price delivery order, issued on December 4, 2025, with completion by December 5, 2025, carries no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the prime contractor with no subcontractors involved in the award.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier capable of fulfilling diverse specialized medical supply requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FSCA8?
SPE2DR26FSCA8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FSCA8 worth?
The government has obligated $100,933 on SPE2DR26FSCA8.
Is contract SPE2DR26FSCA8 an order under another contract?
Yes. SPE2DR26FSCA8 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCA8 competed?
The extent of competition for SPE2DR26FSCA8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award